IMMUNOTHERAPY COMBINATIONS IN STAGE IV CANCER: SYNERGISTIC EFFECTS AND CLINICAL OUTCOMES. FMHR. 2026;4(1):94-107. Accessed January 13, 2026. https://fmhr.net/index.php/fmhr/article/view/1989